Log in to search using one of your social media accounts:

 

Sanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis
PARIS and TARRYTOWN, N.Y., May 22, 2017 /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of Kevzara (sarilumab) for the treatment of adult patients with moderately to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Janssen Biotech goes to court to block launch of Remicade biosimilar
Jansen Biotech is not going to let a second biosimilar version of its blockbuster rheumatoid arthritis drug Remicade hit pharmacy shelves in the United States without a fight. The Horsham, Pa.-based subsidiary of Johnson& Johnson (NYSE: JNJ) has filed a patent infringement lawsuit with U.S. District Court in New Jersey to prevent Samsung Bioepis Co. Ltd. of South Korea from introducing Renflexis later this year. Biosimilar products are different from generic drugs, which are chemically identical… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 19, 2017 Category: American Health Authors: John George Source Type: news

Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy
SEOUL (Reuters) - A unit of healthcare conglomerate Johnson& Johnson filed a lawsuit to block a copy of its rheumatoid arthritis drug Remicade made by South Korea's Samsung Bioepis Co Ltd from being sold in the United States. (Source: Reuters: Health)
Source: Reuters: Health - May 19, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Vegetarian diet could cut obesity risk
Strongest vegetarian diet results in 43% smaller risk of obesity Related items fromOnMedica Mediterranean diet reduces brain shrinkage in elderly Sponsorship and ad bans needed to tackle child obesity Gluten-free diet not recommended for people without coeliac disease Study casts doubts on alternate-day fasting diet Obesity may skew results of rheumatoid arthritis blood tests in women (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 19, 2017 Category: UK Health Source Type: news

Four-week Methotrexate Break Improves Flu Shot Response in RA Patients Four-week Methotrexate Break Improves Flu Shot Response in RA Patients
Temporarily withholding methotrexate (MTX) can improve the efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis (RA), according to a new randomized clinical trial.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 18, 2017 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

A Treat-to-Target Strategy Preserves Work Capacity in RA A Treat-to-Target Strategy Preserves Work Capacity in RA
Find out how a treat-to-target strategy using combination conventional DMARD therapy may help improve work outcomes among rheumatoid arthritis patients.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Trial demonstrates benefits of learning sessions for managing rheumatoid arthritis
(Wiley) A new study found that group-based quality improvement sessions help rheumatologists care for rheumatoid arthritis patients with the recommended 'treat to target' (TTT) approach to care. This approach involves setting a target for treatment, measuring progress towards achieving the target regularly, altering treatments until reaching and maintaining target, and sharing the decisions with patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2017 Category: International Medicine & Public Health Source Type: news

Rheumatoid arthritis: Does pregnancy affect symptoms?
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - May 17, 2017 Category: Consumer Health News Source Type: news

Management Considerations in Cancer Patients With Rheumatoid Arthritis
Patients with cancer and concomitant rheumatoid arthritis pose special challenges. Many therapies for rheumatoid arthritis can increase the risk of adverse events during cancer therapy because they are immunosuppressive. (Source: CancerNetwork)
Source: CancerNetwork - May 15, 2017 Category: Cancer & Oncology Authors: Kristina Goutsouliak, MD Maria E. Suarez-Almazor, MD, PhD Richard J. Zogala, MD Tags: Oncology Journal Source Type: news

Nurses Have A Message For Congress: We Won't Accept 'Lord Of The Flies' Health Care
As scores of red-clad registered nurses stride through the halls of Congressional office buildings this week, they’ll have some other people on their minds. The postal worker who told us his wife was diagnosed with breast cancer and whose disability coverage expired after six months and had to cover thousands of dollars more out of pocket for her treatment. The 57-year-old California contractor who now pays $22,000 a year for health insurance for himself and his wife. “I’m OK with paying high insurance premiums if it helps provide health care for others, but I am mad as hell at the prospect of paying even...
Source: Healthy Living - The Huffington Post - May 9, 2017 Category: Consumer Health News Source Type: news

Welby launches three more apps for pharmas J & J, UCB, and Nippon Shinyaku
Japanese health app maker Welby announced three new apps last month developed in partnership with pharma companies. Welby will add to its lineup three apps available only in Japan: an app for irritable bowel disease patients with Johnson& Johnson subsidiary Janssen; an app for pulmonary arterial hypertension (PAH) patients with Japanese pharma company  Nippon Shinyaku, and an app for rheumatoid arthritis patients with UCB Japan. (Source: mobihealthnews)
Source: mobihealthnews - May 8, 2017 Category: Information Technology Source Type: news

Common rheumatoid arthritis risk factors 'also affect those of African descent'
Genetic and environmental factors associated with rheumatoidarthritis in people from European and Asian backgrounds also apply to people of African ancestry. This is according to a new Arthritis Research UK-funded study led by King's College London, which offers evidence of a shared genetic and environmental underpinning for the disease that is consistent across European, Asian and African ancestry populations. Assessing risk factors among a black British population The study, published in the medical journal Rheumatology, looked at data from 197 people withrheumatoid arthritis and 868 controls in south London, all of ...
Source: Arthritis Research UK - May 4, 2017 Category: Rheumatology Source Type: news

Heart attack - if YOU suffer with symptoms of THIS condition you could be at risk
RHEUMATOID arthritis sufferers are more at risk of developing a condition called atherosclerosis, a chronic inflammatory condition affecting the heart which can increase the likelihood of having a deadly heart attack. (Source: Daily Express - Health)
Source: Daily Express - Health - May 3, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis sufferers could be at greater risk of THIS silent killer
RHEUMATOID arthritis sufferers are more at risk of developing a condition called atherosclerosis, a chronic inflammatory condition affecting the heart. (Source: Daily Express - Health)
Source: Daily Express - Health - May 3, 2017 Category: Consumer Health News Source Type: news

Regeneron and Sanofi Announce Kevzara(R) (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA
New action date for Kevzara U.S. BLA is May 22, 2017 TARRYTOWN, N.Y. and PARIS, April 28, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administra... Biopharmaceuticals Regeneron Pharmaceuticals, Sanofi, Kevzara, sarilumab, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 28, 2017 Category: Pharmaceuticals Source Type: news

TfL launches badge to recognise customers with invisible impairments
(Source: TfL)Transport for London (TfL) has launched a‘Please offer me a seat’ badge to recognise customers with invisible impairments.The‘Please Offer Me a Seat’ badge and card was created following requests from customers, particularly those with invisible impairments, conditions and illnesses, who struggle to get a seat as their need for one isn’t immediately obvious.A six-week trial with 1,200 users was held in autumn last year to test if the badge and card would help people getting a seat. Over the course of the trial, participants’ confidence in using the network increased. More th...
Source: Arthritis Research UK - April 27, 2017 Category: Rheumatology Source Type: news

Can-Fite to begin Phase III trial of piclidenoson in Israel to treat rheumatoid arthritis
Biotechnology company Can-Fite BioPharma has obtained approval from the Institutional Review Board (IRB) of Barzilai Medical Center in Israel, to begin patient enrolment in the Phase III ACRobat clinical trial of piclidenoson for the treatment of rhe … (Source: Drug Development Technology)
Source: Drug Development Technology - April 26, 2017 Category: Pharmaceuticals Source Type: news

Cost controls help offset lower Amgen first-quarter drug sales
(Reuters) - Amgen Inc on Wednesday reported higher-than-expected first-quarter profit as cost controls helped offset a sharp drop in sales of Enbrel, its blockbuster rheumatoid arthritis and psoriasis drug. (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
Title: Early Treatment Equals Better Results for Rheumatoid ArthritisCategory: Health NewsCreated: 4/25/2017 12:00:00 AMLast Editorial Review: 4/26/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - April 26, 2017 Category: Rheumatology Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
Study found less disability, lower risk of early deathSource: HealthDay Related MedlinePlus Pages: Autoimmune Diseases, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 25, 2017 Category: Consumer Health News Source Type: news

Eli Lilly ’ s diabetes drugs boost Q1 revenue, earnings
Shares in Eli Lilly (NYSE:LLY) fell slightly today as the company met expectations on Wall Street with its 1st quarter financial results. The company has faced its share of issues in the last year – Lilly took a $150 million hit in November after its Alzheimer’s drug failed in a clinical trial and this month, the FDA rejected its rheumatoid arthritis drug. But the company’s diabetes therapies, such as Trulicity and Humalog, helped to propel the company to an adjusted quarterly profit that beat expectations on The Street. “We are encouraged by another solid performance from Lilly’s ov...
Source: Mass Device - April 25, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Diabetes MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Eli Lilly & Co. Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
TUESDAY, April 25, 2017 -- Treating rheumatoid arthritis early may make for better outcomes, a new study suggests. Patients who were treated within six months of developing the first signs of the autoimmune disease did better in the long run and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 25, 2017 Category: Journals (General) Source Type: news

Sanofi and Regeneron ’s Kevzara receives CHMP opinion to treat Rheumatoid Arthritis
Regeneron Pharmaceuticals and Sanofi ’s Kevzara (sarilumab) has received a positive opinion from the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) to treat adult patients with moderately to severely active rheu… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 24, 2017 Category: Pharmaceuticals Source Type: news

Rheumatoid arthritis patients 'at an increased risk of atherosclerosis'
This study confirms increased prevalence of atherosclerosis in rheumatoid arthritis and provides data to support the hypothesis that patients have a high-risk plaque phenotype." Arthritis Research UK's view Dr Natalie Carter, head of research liaison and evaluation at Arthritis Research UK, said:"Rheumatoid arthritis is an incredibly debilitating condition that affects more than 400,000 people within the UK. The condition can not only limit a person's ability to live their everyday life to the full, but it can also put them at higher risk of cardiovascular disease. "This study not only reinforces the...
Source: Arthritis Research UK - April 24, 2017 Category: Rheumatology Source Type: news

Early Treatment Boosts Long-term Rheumatoid Arthritis Outcomes Early Treatment Boosts Long-term Rheumatoid Arthritis Outcomes
Early treatment boosts long-term arthritis outcomes and may be contributing to lower arthritis-related mortality, two new studies suggested.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara(R) (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
TARRYTOWN, N.Y. and PARIS, April 24, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP... Biopharmaceuticals, Regulatory Regeneron Pharmaceuticals, Sanofi, Kevzara, sarilumab, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2017 Category: Pharmaceuticals Source Type: news

Early Treatment Boosts Long-Term Arthritis Outcome
Early Treatment Boosts Long-Term Rheumatoid Arthritis Outcomes (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 24, 2017 Category: Journals (General) Source Type: news

FDA approves Samsung Bioepis' copy of J & J's Remicade: company
SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson& Johnson's rheumatoid arthritis drug Remicade, the first drug developed by the Samsung Group unit approved in the United States. (Source: Reuters: Health)
Source: Reuters: Health - April 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

EU Regulators OK Sarilumab (Kevzara) for Rheumatoid Arthritis EU Regulators OK Sarilumab (Kevzara) for Rheumatoid Arthritis
A committee of the European Medicines Agency also recommended approval of Erelzi, a biosimilar to entanercept that treats six different inflammatory disorders.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 21, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

FDA approves 2nd near-copy of Remicade for immune disorders
Federal regulators have approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders (Source: ABC News: Health)
Source: ABC News: Health - April 21, 2017 Category: Consumer Health News Tags: Health Source Type: news

EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
(Reuters) - A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron's experimental drug to treat rheumatoid arthritis. (Source: Reuters: Health)
Source: Reuters: Health - April 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Patient-Reported Outcomes and MRI Measures in RA Patient-Reported Outcomes and MRI Measures in RA
Are MRI measures associated with patient-reported outcomes among those with rheumatoid arthritis?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 21, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Studies examine rheumatoid arthritis patients' prognosis
(Wiley) What's the long-term outlook for today's patients with early rheumatoid arthritis? A new study in Arthritis& Rheumatology that looks at patients' mortality, disease activity, and physical function over the course of 20 years reveals the importance of early treatment. Another study in the journal notes that deaths from arthritis are declining. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 20, 2017 Category: Global & Universal Source Type: news

Rheumatoid arthritis medications: Dangerous during pregnancy?
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - April 20, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis cure: Symptoms halted by doing THIS (it could prevent joint damage)
RHEUMATOID ARTHRITIS sufferers have been sent a lifeline thanks to a new study which found early treatment can reduce symptoms for years afterwards. (Source: Daily Express - Health)
Source: Daily Express - Health - April 19, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis patients 'have experienced progress in recent decades'
This study confirms how important early diagnosis and the commencement of treatment is. It is also encouraging to hear about the progress that has been made over the last 20 years. "Now the scientific community must continue to build on this, so that together we can continue to harness the power of exceptional science and make everyday life better for all people with arthritis." (Source: Arthritis Research UK)
Source: Arthritis Research UK - April 18, 2017 Category: Rheumatology Source Type: news

RA Patients May Benefit From Using a Pedometer RA Patients May Benefit From Using a Pedometer
Patients with rheumatoid arthritis (RA) who receive pedometers may be more active and feel less fatigued even if they are not told to use the trackers to aim for a specific number of steps, a small study suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 18, 2017 Category: Orthopaedics Tags: Rheumatology News Source Type: news

US FDA declines approval of Eli Lilly and Incyte ’s baricitinib drug to treat RA
Eli Lilly and partner Incyte have announced that the US Food and Drug Administration (FDA) has declined to approve a new drug, baricitinib, to treat moderate-to-severe rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 17, 2017 Category: Pharmaceuticals Source Type: news

FDA Says'No' to Baricitinib for Rheumatoid Arthritis
(MedPage Today) -- Dosages and safety were noted as concerns (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 17, 2017 Category: American Health Source Type: news

Tofacitinib for Rheumatoid Arthritis and Plaque Psoriasis Tofacitinib for Rheumatoid Arthritis and Plaque Psoriasis
Review the latest data on the oral immunosuppressant tofacitinib, recently approved for the treatment of rheumatoid arthritis, and currently in Phase III trials for treating chronic plaque psoriasis.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Unichem Labs gets USFDA nod for arthritis drug
Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2017 Category: Pharmaceuticals Source Type: news

Rheumatoid arthritis and cardiovascular risk: Mayo Clinic Radio Health Minute
In this Mayo Clinic Radio Health Minute, we hear from Dr. Eric Matteson on the increased cardiovascular risk for women with rheumatoid arthritis. To listen, click the link below. RA and CV Risk (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 17, 2017 Category: Databases & Libraries Source Type: news

Pedometers tied to less fatigue for rheumatoid arthritis patients
(Reuters Health) - Patients with rheumatoid arthritis who receive pedometers may be more active and feel less fatigued even if they are not told to use the trackers to aim for a specific number of steps, a small study suggests. (Source: Reuters: Health)
Source: Reuters: Health - April 14, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. FDA Issues Complete Response Letter for Baricitinib
INDIANAPOLIS, April 14, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for th... Biopharmaceuticals, FDA Eli Lilly, Incyte, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2017 Category: Pharmaceuticals Source Type: news

U.S. FDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday declined to approve a new drug for rheumatoid arthritis made by Eli Lilly and Co and partner Incyte Corp, the companies said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - April 14, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Diet and Risk for Rheumatoid Arthritis Diet and Risk for Rheumatoid Arthritis
Dr Kevin Deane highlights a new study exploring how a healthy diet can influence the risk of developing rheumatoid arthritis.Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2017 Category: Consumer Health News Tags: Rheumatology Viewpoint Source Type: news

Obesity influences rheumatoid arthritis diagnostic tests
Obesity causes patients to receive higher scores in blood tests used to diagnose rheumatoid arthritis even if they do not have the condition, researchers have warned. (Source: GP Online News)
Source: GP Online News - April 11, 2017 Category: Primary Care Tags: 15.9 Rheumatology, Musculoskeletal and Trauma Source Type: news

Palindromic rheumatism: Precursor to rheumatoid arthritis?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - April 11, 2017 Category: Consumer Health News Source Type: news